120 related articles for article (PubMed ID: 36546327)
1. Tempol differential effect on prostate cancer inflammation: In vitro and in vivo evaluation.
Rossetto I; Santos F; Kido L; Lamas C; Montico F; Cagnon V
Prostate; 2023 Apr; 83(5):403-415. PubMed ID: 36546327
[TBL] [Abstract][Full Text] [Related]
2. Tempol effect on oxidative and mitochondrial markers in preclinical models for prostate cancer.
Rossetto IMU; Santos FR; da Silva HM; Minatel E; Mesquitta M; Salvador MJ; Montico F; Cagnon VHA
Toxicol Res (Camb); 2024 Apr; 13(2):tfae056. PubMed ID: 38623092
[TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory therapies in TRAMP mice: delay in PCa progression.
Kido LA; Montico F; Sauce R; Macedo AB; Minatel E; Costa DB; Carvalho JE; Pilli RA; Cagnon VH
Endocr Relat Cancer; 2016 Apr; 23(4):235-50. PubMed ID: 26772819
[TBL] [Abstract][Full Text] [Related]
4. Nintedanib antiangiogenic inhibitor effectiveness in delaying adenocarcinoma progression in Transgenic Adenocarcinoma of the Mouse Prostate (TRAMP).
da Silva RF; Nogueira-Pangrazi E; Kido LA; Montico F; Arana S; Kumar D; Raina K; Agarwal R; Cagnon VHA
J Biomed Sci; 2017 May; 24(1):31. PubMed ID: 28499383
[TBL] [Abstract][Full Text] [Related]
5. Differential tempol effects in prostatic cancer: angiogenesis and short- and long-term treatments.
Santos FR; Rossetto IMU; Montico F; de Almeida Lamas C; Cagnon VHA
J Mol Histol; 2024 Mar; ():. PubMed ID: 38551737
[TBL] [Abstract][Full Text] [Related]
6. Ectopic fibroblast growth factor receptor 1 promotes inflammation by promoting nuclear factor-κB signaling in prostate cancer cells.
Wang C; Ke Y; Liu S; Pan S; Liu Z; Zhang H; Fan Z; Zhou C; Liu J; Wang F
J Biol Chem; 2018 Sep; 293(38):14839-14849. PubMed ID: 30093411
[TBL] [Abstract][Full Text] [Related]
7. Tempol reduces the activation of nuclear factor-kappaB in acute inflammation.
Cuzzocrea S; Pisano B; Dugo L; Ianaro A; Patel NS; Caputi AP; Thiemermann C
Free Radic Res; 2004 Aug; 38(8):813-9. PubMed ID: 15493454
[TBL] [Abstract][Full Text] [Related]
8. Expression of NF-κB-related proteins and their modulation during TNF-α-provoked apoptosis in prostate cancer cells.
Rodríguez-Berriguete G; Fraile B; Paniagua R; Aller P; Royuela M
Prostate; 2012 Jan; 72(1):40-50. PubMed ID: 21520161
[TBL] [Abstract][Full Text] [Related]
9. Constitutive activation of P I3 K-Akt and NF-kappaB during prostate cancer progression in autochthonous transgenic mouse model.
Shukla S; Maclennan GT; Marengo SR; Resnick MI; Gupta S
Prostate; 2005 Aug; 64(3):224-39. PubMed ID: 15712212
[TBL] [Abstract][Full Text] [Related]
10. Loss of MyD88 leads to more aggressive TRAMP prostate cancer and influences tumor infiltrating lymphocytes.
Peek EM; Song W; Zhang H; Huang J; Chin AI
Prostate; 2015 Apr; 75(5):463-73. PubMed ID: 25597486
[TBL] [Abstract][Full Text] [Related]
11. The role of IKK in constitutive activation of NF-kappaB transcription factor in prostate carcinoma cells.
Gasparian AV; Yao YJ; Kowalczyk D; Lyakh LA; Karseladze A; Slaga TJ; Budunova IV
J Cell Sci; 2002 Jan; 115(Pt 1):141-51. PubMed ID: 11801732
[TBL] [Abstract][Full Text] [Related]
12. Alpha-tomatine attenuation of in vivo growth of subcutaneous and orthotopic xenograft tumors of human prostate carcinoma PC-3 cells is accompanied by inactivation of nuclear factor-kappa B signaling.
Lee ST; Wong PF; He H; Hooper JD; Mustafa MR
PLoS One; 2013; 8(2):e57708. PubMed ID: 23437404
[TBL] [Abstract][Full Text] [Related]
13. Constitutive activation of IkappaB kinase alpha and NF-kappaB in prostate cancer cells is inhibited by ibuprofen.
Palayoor ST; Youmell MY; Calderwood SK; Coleman CN; Price BD
Oncogene; 1999 Dec; 18(51):7389-94. PubMed ID: 10602496
[TBL] [Abstract][Full Text] [Related]
14. Interleukin 6, a nuclear factor-kappaB target, predicts resistance to docetaxel in hormone-independent prostate cancer and nuclear factor-kappaB inhibition by PS-1145 enhances docetaxel antitumor activity.
Domingo-Domenech J; Oliva C; Rovira A; Codony-Servat J; Bosch M; Filella X; Montagut C; Tapia M; Campás C; Dang L; Rolfe M; Ross JS; Gascon P; Albanell J; Mellado B
Clin Cancer Res; 2006 Sep; 12(18):5578-86. PubMed ID: 17000695
[TBL] [Abstract][Full Text] [Related]
15. Oncogenic miR-210-3p promotes prostate cancer cell EMT and bone metastasis via NF-κB signaling pathway.
Ren D; Yang Q; Dai Y; Guo W; Du H; Song L; Peng X
Mol Cancer; 2017 Jul; 16(1):117. PubMed ID: 28693582
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory mediators of prostate epithelial cells stimulated with Trichomonas vaginalis promote proliferative and invasive properties of prostate cancer cells.
Han IH; Kim JH; Jang KS; Ryu JS
Prostate; 2019 Jul; 79(10):1133-1146. PubMed ID: 31050003
[TBL] [Abstract][Full Text] [Related]
17. Effect of Eriocalyxin B on prostatic inflammation and pelvic pain in a mouse model of experimental autoimmune prostatitis.
Zhang LG; Yu ZQ; Yang C; Chen J; Zhan CS; Chen XG; Zhang L; Hao ZY; Liang CZ
Prostate; 2020 Dec; 80(16):1394-1404. PubMed ID: 32965686
[TBL] [Abstract][Full Text] [Related]
18. Association of anti-inflammatory and antiangiogenic therapies negatively influences prostate cancer progression in TRAMP mice.
Mateus PAM; Kido LA; Silva RS; Cagnon VHA; Montico F
Prostate; 2019 Apr; 79(5):515-535. PubMed ID: 30585351
[TBL] [Abstract][Full Text] [Related]
19. CD4
Liu S; Liu F; Zhang B; Yan P; Rowan BG; Abdel-Mageed AB; Steele C; Jazwinski SM; Moroz K; Norton EB; Wang A; Myers L; Sartor O; Zhang Q
Prostate; 2020 Jul; 80(10):764-776. PubMed ID: 32356608
[TBL] [Abstract][Full Text] [Related]
20. Il-1 beta-induced post-transition effect of NF-kappaB provides time-dependent wave of signals for initial phase of intrapostatic inflammation.
Vykhovanets EV; Shukla S; MacLennan GT; Vykhovanets OV; Bodner DR; Gupta S
Prostate; 2009 May; 69(6):633-43. PubMed ID: 19170127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]